Zobrazeno 1 - 10
of 785
pro vyhledávání: ''
Autor:
Atif Ali Hashmi, Syeda Narisa Iftikhar, Shahzeb Munawar, Omer Ahmed, Syed Rafay Yaqeen, Ishaq Azeem Asghar, Muhammad Irfan, Javaria Ali, Muhammad M. Edhi, Shumaila Kanwal Hashmi
Publikováno v:
Cancer Investigation. 40:211-218
In this study, we evaluated the association of ISUP/WHO-grade groups with various pathological prognostic parameters and cancer-specific survival in patients with prostatic adenocarcinoma. We found 27 (15.7%) cases of grade group 1, 22 (12.8%) grade
Autor:
Babak PeyroShabany, Mansoureh Dehghani, Seyed Alireza Javadinia, Danial Fazilat-Panah, Pejman Porouhan, Farbod Hatami, James S Welsh, Maryam Nabavifard, Mona Ariamanesh, Mohammad Fereidouni
Publikováno v:
Cancer Investigation
article-version (VoR) Version of Record
article-version (VoR) Version of Record
ObjectivePatients with malignancy suffer from a compromised immune system due to either the effects of malignancies or treatments. Cancer patients are at higher risk of different infections particularly SARS-CoV2 and usually produce weaker response t
Publikováno v:
Cancer Investigation. 40:124-131
BACKGROUND Large Cell Neuroendocrine Carcinoma of the Lung (L-LCNEC) is a rare type of neuroendocrine lung cancer that is increasingly diagnosed. However, the optimal management regarding the advanced stage is unclear. The purpose of this article is
Autor:
Kaibin Zhu, Xiaoyu Zheng, Yubo Yan, Jinfeng Ning, Jianlong Bu, Jian Zhang, Xidong Zhu, Shidong Xu, Su Zhao, Mengfeng Liu
Publikováno v:
Cancer Investigation. 40:91-102
Surgical removal of the tumor is currently the first-line treatment for lung cancer, but the procedure may accelerate cancer progression through immunosuppression. However, whether CCL2 (C-C motif chemokine ligand 2) enhances cancer progression by af
Publikováno v:
Cancer Investigation. 39:734-740
BACKGROUND The purpose of this study was to compare survival outcomes in patients with perineural invasion (PNI)-positive laryngeal squamous cell carcinoma (LSCC) and patients with PNI-negative LSCC. METHODS A total of 1,272 patients with LSCC, diagn
Autor:
Attalla F. El-kott, Nora A Farag, Nadia El-Menshawy, Hayam Fathi Ghazi, Doaa Atia, Eman Fawzi, Doaa A. Shahin, Mohamed Eissa, Nashwa K. Abousamra
Publikováno v:
Cancer Investigation. 39:777-782
OBJECTIVE Multiple myeloma is an incurable hematological malignancy. Currently, the use of proteasome inhibitors could be superior to chemotherapy-based regimen in the treatment of this disease. However, resistance to bortezomib combination therapy s
Publikováno v:
Cancer Investigation. 39:645-652
The aim of the study was to report long-term results of intensity-modulated radiotherapy for patients with T4 classification nasopharyngeal carcinoma (NPC). From September 2007 to January 2013, 155 patients were retrospectively analyzed. The estimate
Publikováno v:
Cancer Investigation. 39:597-606
Fourty-five breast cancer patients and 50 apparently healthy sex-matched controls from the University of Ilorin Teaching Hospital were enrolled in this study. Plasma D-dimer and fibrinogen were found to be significantly higher than controls; APTT was
Autor:
Beatriz Castelo, Jacobo Rogado, Paula Jiménez-Fonseca, Eva Martínez de Castro, Raquel Hernández, Oliver Higuera, Alberto Carmona-Bayonas, Ismael Ghanem, María del Mar Muñoz, Caterina Calderon
Publikováno v:
Cancer Investigation. 39:589-596
The aim of this study was to compare physicians' and patients' estimates of risk of relapse and toxicity. A prospective, cross-sectional, multicenter study including 735 patients with cancer and 29 oncologists. Physicians' appraisals of risk of relap
Publikováno v:
Cancer Investigation. 39:582-588
Proton therapy (PT) is an important component of therapy for select cancers, but no formal study of geospatial access to PT has been conducted to date. Population data for 320.7 million people in 32,644 zip codes were analyzed. Median travel time was